Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 26578771.
- Also identified by DOI 10.1073/pnas.1518628112 and PMC identifier 4655568.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thrombocytosis and platelet hyperreactivity are known to be associated with malignancy; however, there have been no ultrastructure studies of platelets from patients with ovarian cancer. Here, we used electron cryotomography (cryo-ET) to examine frozen-hydrated platelets from patients with invasive ovarian cancer (n = 12) and control subjects either with benign adnexal mass (n = 5) or free from disease (n = 6). Qualitative inspections of the tomograms indicate significant morphological differences between the cancer and control platelets, including disruption of the microtubule marginal band. Quantitative analysis of subcellular features in 120 platelet electron tomograms from these two groups showed statistically significant differences in mitochondria, as well as microtubules. These structural variations in the platelets from the patients with cancer may be correlated with the altered platelet functions associated with malignancy. Cryo-ET of platelets shows potential as a noninvasive biomarker technology for ovarian cancer and other platelet-related diseases.
Medical subject headings
- Biomarkers, Tumor
- Blood Platelets
- Cryoelectron Microscopy
- Microtubules
- Mitochondria
- Ovarian Neoplasms